Botulinum Neurotoxin A4 Has a 1000-Fold Reduced Potency Due to Three Single Amino Acid Alterations in the Protein Receptor Binding Domain
Botulinum neurotoxin subtype A4 (BoNT/A4) is ~1000-fold less potent than BoNT/A1. This study addresses the basis for low BoNT/A4 potency. Utilizing BoNT/A1-A4 and BoNT/A4-A1 Light Chain-Heavy Chain (LC-HC) chimeras, HC-A4 was responsible for low BoNT/A4 potency. Earlier studies showed BoNT/A1-recept...
Main Authors: | William H. Tepp, Marite Bradshaw, Alexander P. Gardner, Rebecca L. Kaufman, Joseph T. Barbieri, Sabine Pellett |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/6/5690 |
Similar Items
-
Botulinum neurotoxin X lacks potency in mice and in human neurons
by: Brieana M. Gregg, et al.
Published: (2024-03-01) -
Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6
by: Molly S. Moritz, et al.
Published: (2018-10-01) -
Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM
by: Sara Košenina, et al.
Published: (2021-12-01) -
Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism
by: Robert P. Webb, et al.
Published: (2017-09-01) -
Humoral Response of Buffaloes to a Recombinant Vaccine against Botulism Serotypes C and D
by: Denis Y. Otaka, et al.
Published: (2017-09-01)